Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: OEIC
  • Objective: European Reg. ex UK
  • Asset Class: Equity
  • Geographic Focus: European Reg. ex UK

F&C Investment Funds ICVC - European Growth & Income Fund

+ Add to Watchlist

RSLEU3I:LN

879.00 GBp 6.80 0.78%

As of 09:58:06 ET on 01/30/2015.

Snapshot for F&C Investment Funds ICVC - European Growth & Income Fund (RSLEU3I)

Year To Date: +4.46% 3-Month: +7.81% 3-Year: +18.07% 52-Week Range: 748.70 - 879.00
1-Month: +4.46% 1-Year: +10.10% 5-Year: +11.22% Beta vs FTWIWXUK: 0.96

Mutual Fund Chart for RSLEU3I

No chart data available.
  • RSLEU3I:LN 879.00
  • 1M
  • 1Y
Interactive RSLEU3I Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RSLEU3I

F&C Investment Funds ICVC - European Growth & Income Fund is an open-end investment company incorporated in the United Kingdom. The Fund aims to achieve medium to long-term growth and income. The Fund invests primarily in European equities.

Inception Date: 10-25-1999 Telephone: 44-870-601-6183
Managers: MARK NICHOLS
Web Site: www.fandc.co.uk

Fundamentals for RSLEU3I

NAV (on 2015-01-30) 879.00
Assets (M) (on 2014-11-20) 352.88
Fund Leveraged N
Minimum Investment 50,000,000.00
Minimum Subsequent Investment 25,000.00

Dividends for RSLEU3I

Dividend Type Accumulation
Dividend Frequency Annual
Last Dividend Net (on 2014-05-01) 16.95
Dividend Yield (ttm) 2.14

Fees & Expenses for RSLEU3I

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.40
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.47

Top Fund Holdings for RSLEU3I

Filing Date: 11/30/2014
Name Position Value % of Total
Novartis AG 354,150 21,939,260 6.012%
Roche Holding AG 94,404 18,103,108 4.961%
Svenska Handelsbanken AB 475,903 14,873,923 4.076%
Allianz SE 124,578 13,704,821 3.756%
Reed Elsevier NV 811,775 12,778,390 3.502%
SAP SE 247,663 11,185,990 3.065%
Wolters Kluwer NV 585,241 10,979,239 3.009%
Bayer AG 109,021 10,472,526 2.870%
Unilever NV 369,159 9,700,352 2.658%
Deutsche Post AG 451,962 9,598,685 2.630%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil